Plavix

Showing 14 posts of 29 posts found.

Brilique gains NICE approval

October 31, 2011
Sales and Marketing ACS, Brilique, NICE, Plavix, clopidogrel

AstraZeneca’s Brilique has been approved by NICE for use in combination with aspirin as an option to treat patients with …

Sanofi-Aventis' Plavix (clopidogrel)

Plavix sales plummet in England

May 5, 2011
Sales and Marketing BMS, Plavix, Sanofi-Aventis, clopidogrel

GP prescriptions for Plavix saw a significant drop in England last year as doctors opted for cheaper generic forms of …

AZ’s Brilique approved in Europe

December 7, 2010
Sales and Marketing AZ, AstraZeneca, Brilique, Plavix, acute coronary syndromes, antiplatelet, atherothrombotic events, ticagrelor

European regulator have approved AstraZeneca’s oral antiplatelet Brilique (ticagrelor tablets). Brilique can now be used for the prevention of atherothrombotic …

Genzyme again snubs suitor Sanofi

November 10, 2010
Research and Development, Sales and Marketing Campath, Chris Viehbacher, Genzyme, Henri Termeer, Orphan Drugs, Plavix, Sanofi, Sanofi-Aventis, manufacturing compliance

Genzyme has once again snubbed Sanofi-Aventis as the French pharma firm continues its pursuit of the beleaguered biotech company. Henri …

AstraZeneca’s Brilinta delayed

September 16, 2010
Sales and Marketing Brillinta, Effient, Plavix, clopidogrel

AstraZeneca’s blood thinning drug Brilinta faces an extra three month delay to its review by the FDA. The US regulator …

Generic clopidogrel helps NICE recommend blood clot prevention

August 5, 2010
Sales and Marketing NICE, Plavix

NICE has given preliminary approval for wider use of Sanofi-Aventis’s Plavix and Boehringer Ingelheim’s Persantine to prevent blood clots. It …

Sanofi under investigation for anti-competitive practices

May 20, 2010
Sales and Marketing Plavix, Sanofi

Sanofi-Aventis is to be investigated by the French Competition Authority for anti-competitive practices, following allegations it prevented the launch of …

In search of a real solution to the counterfeit problem

May 10, 2010
Manufacturing and Production Plavix, counterfeits, supply chain

For a great deal of the last decade, warnings from the pharmaceutical industry about the growing threat of counterfeit medicines …

Plavix boosts BMS first quarter figures

April 30, 2010
Sales and Marketing BMS, Plavix

Plavix has boosted Bristol-Myers Squibb’s performance in the first quarter of the year, with sales of the anti-clotting blockbuster up …

EMA calls for generic clopidogrel recall

March 31, 2010
Manufacturing and Production Plavix, clopidogrel

Problems at a manufacturing facility in India have resulted in eight generic version of the antiplatelet agent clopidogrel being recalled …

FDA strengthens Plavix safety warning

March 15, 2010
Sales and Marketing Plavix

A boxed warning has been added to the US packaging of Sanofi-Aventis and Bristol-Myers Squibb’s blockbuster anti-clotting drug Plavix. The …

Sanofi’s Plavix combination recommended for European approval

December 21, 2009
Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux

Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …

Plavix to face six generic competitors in Europe

June 17, 2009
Sales and Marketing Plavix, Sanofi-Aventis

Plavix is to face competition from six generics in Europe, potentially decimating sales of Sanofi-Aventis' brand in the region. Plavix …

Plavix sales help BMS into profit

January 29, 2009
Sales and Marketing BMS, Plavix

Strong fourth quarter sales of its blockbuster blood thinner Plavix have helped Bristol-Myers Squibb back into the black. Net earnings …

The Gateway to Local Adoption Series

Latest content